Vial - lyophilised powderSubcutaneous (SQ)BPC-157 5 mg + GHK-Cu 50 mg

GLOW brings BPC 157 and GHK Cu together in one formulation. The pairing connects two areas of peptide research: tissue recovery and skin quality. It is an interesting combination for the conversation around repair and aesthetics, although the finished blend needs its own evidence rather than borrowing every claim from its ingredients.

Shipping Information
Shipping Information

Free Shipping

Decor Outdoor offers free regular shipping on all orders shipped to residential or commercial addresses within the contiguous United States. Orders are delivered Monday through Friday (excluding holidays).

Drop Shipping

We are an online-only luxury furniture and lighting boutique, and do not have a warehouse. Consequently, all orders are drop shipped directly from our manufacturers to your door. If your order includes items from more than one manufacturer, you will receive multiple deliveries. Because we are dependent on the on-hand inventory of our manufacturing partners, some items listed on our site may not actually be available right away. Please call us at 888.784.4644 or via our contact form with any stocking questions and we'll get in touch with the appropriate manufacturer for answers, before you place your order.

Ground Shipping

Small parcel items ship regular ground via delivery services such as FedEx, UPS or DHL. Orders typically take 2-3 business days to process and in-stock items will usually be delivered 3-5 days from the date that they ship (depending on origin and destination). If there is a delay, you will be notified by email. No signature is required for standard ground shipping, so you may want to make arrangements to have packages brought inside soon after delivery, if you are unable to receive it in person.
Storage & Handling

Follow the storage instructions on your product label and the information supplied with your batch. Storage and handling requirements vary by product and presentation.

GLOW combines BPC 157 with the copper peptide GHK Cu. The interest is in bringing research around tissue repair alongside research into collagen and skin structure.

Where It Fits

Tissue recovery and skin quality research. Evidence for the two ingredients is not the same as evidence for this blend.

The PHI Perspective

A combination should have a clear reason to exist. We explain what each ingredient contributes without assuming that combining them proves a better result.

For clinician-directed use only where permitted.

How It Works

BPC 157 is studied around repair signals. GHK Cu is studied around the proteins and processes that give skin and connective tissue their structure. The combined effect remains a separate research question.

What the Research Suggests

The ingredients have been studied separately, but that does not establish the effect or safety of this finished combination. Direct evidence for the blend needs to be assessed on its own.

Evidence level: D. Combination unstudied; component evidence preclinical to limited-human

Storage & Handling

Store lyophilised vial at 2-8 C, protected from light. Copper peptides are light-sensitive; keep in outer carton.

Active compound: BPC-157 5 mg + GHK-Cu 50 mg (combination)

Mechanism of Action

Dual mechanism. BPC-157 promotes VEGFR2-mediated angiogenesis and organised granulation tissue formation. GHK-Cu acts as a copper carrier, modulating expression of genes governing collagen, elastin and glycosaminoglycan synthesis, and influencing matrix metalloproteinase and TIMP balance during remodelling.

Clinical Evidence Base

Component-level evidence only. GHK-Cu has controlled human data in topical dermatological application. BPC-157 evidence is preclinical. The fixed combination has not been evaluated in any published human or animal study, and no synergy has been demonstrated.

Safety & Precautions

Carries the combined precautions of both components. Copper content is the principal consideration: contraindicated in Wilson's disease and used with caution where copper handling may be impaired. Theoretical angiogenic concern in occult malignancy. Not for use in pregnancy or breastfeeding. Injection-site reactions and transient discolouration at the site have been reported with copper peptides.

Contraindications

Wilson's disease or other disorders of copper metabolism; active or suspected malignancy; pregnancy and breastfeeding; known hypersensitivity.

Literature & References

Refer to component literature for BPC-157 and GHK-Cu. No combination-specific literature exists. | Pickart L, Margolina A. Int J Mol Sci, 2018 - GHK-Cu biological actions. | Sikiric P et al. Curr Pharm Des, 2011 - BPC 157 overview.

Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Availability
  • Add to cart
  • Description
  • Content
  • Weight
  • Dimensions
  • Additional information
Click outside to hide the comparison bar
Compare